ConductScience.org, home
X-linked dominant hypophosphatemic rickets
API referenceFor AI assistants

Disease · MONDO_0010619

Comparisons in its trials16

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

1 to 16 of 16

Download this page as JSON
ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
Burosumab Q2W vs Burosumab Q4W Then Q2W: deaths from any cause0 of 260 of 2652NCT02163577Trial comparisons
Burosumab Q2W vs Burosumab Q4W Then Q2W: serious adverse events0 of 261 of 2652NCT02163577Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Nasal Ulceration at 1 Month0 of 102 of 1121NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Nasal Congestion at 1 Month3 of 102 of 1121NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Allergic Reactions at 1 Month0 of 100 of 1121NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Patients With Nasal Congestion at Baseline0 of 100 of 1121NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Allergic Reactions at Baseline0 of 100 of 1121NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Nasal Ulcerations at Baseline0 of 100 of 1121NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: deaths from any cause0 of 100 of 1121NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: serious adverse events0 of 100 of 1121NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Nasal Ulceration at 2 Months0 of 100 of 1020NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Nasal Congestion at 2 Months1 of 100 of 1020NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Nasal Ulcerations at 3 Months0 of 101 of 1020NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Allergic Reactions at 3 Months0 of 100 of 1020NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Allergic Reactions at 2 Months0 of 100 of 1020NCT01652573Trial comparisons
Nasal Calictonin vs Saline Nasal Spray: Number of Participants With Nasal Congestion at 3 Months0 of 100 of 1020NCT01652573Trial comparisons

diseases-2026-09-18-0.1.0

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0010619/comparisons

API referenceFor AI assistants